US COPD Coalition

NIH

Apr
14

NIH begins trial of anti-CD14 antibody to treat respiratory disease caused by COVID-19

The following article is re-printed from a news release issued by the National Institutes of Health. A clinical trial testing the safety and efficacy of an investigational monoclonal antibody for treating people who are hospitalized with respiratory disease and low blood oxygen due to infection with SARS-CoV-2, the virus that causes COVID-19, has begun. The … Read more

Feb
1

NIH study shows hyaluronan is effective in treating chronic lung disease

The following article is re-printed from a news release by the National Institutes of Health Naturally produced by the body, hyaluronan represents a new class of biologic that significantly improves lung health in patients with severe COPD. Researchers at the National Institutes of Health and their collaborators found that inhaling unfragmented hyaluronan improves lung function … Read more

Dec
3

New updates to federal guidelines revamp asthma management

The following is a news release from the National Institutes of Health. Updates to six key areas of asthma care focus on improving diagnosis, management and treatment. The National Institutes of Health today announced 19 recommendations in six key areas of asthma diagnosis, management and treatment. The new guidance, published in the Journal of Allergy and … Read more